Drug firms Novo Nordisk and Sanofi have highlighted the logistics challenges in post-Brexit pharmaceutical imports, and in particular insulin where almost all supplies come from the EU. Import tariffs may have lost their bite in the U.S. solar power sector. Also: Posco, Hyundai Steel may be caught up in India’s SIMS; Abe loses leverage as Japanese trade activity slides; India’s Iranian rice problem may find a fix in Indonesia; Destination Maternity not alone in facing tough market, tariff tantrums; Saudi oil supply chain shortage should be limited to September; Paris could...